7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Jaw Diseases D007571 4 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Kidney Diseases D007674 29 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Labyrinthitis D007762 2 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Leukemia D007938 74 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Huang P et al. [In vitro study of combination rhOPG-Fc and alendronate on inhibition osteoclast]. 2005 Zhonghua Wai Ke Za Zhi pmid:16083587
Chen HX et al. [Serum osteoprotegerin as a novel marker of bone metastasis in prostate cancer]. 2007 Zhonghua Wai Ke Za Zhi pmid:17537330
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Xu ML et al. [An update for the research progress of osteoprotegerin on coronary artery disease]. 2011 Zhonghua Xin Xue Guan Bing Za Zhi pmid:22321243
Zhang JH et al. [Effects of the osteoclast in pathogenesis of multiple myeloma]. 2007 Zhonghua Xue Ye Xue Za Zhi pmid:17877161
Zhao ZM et al. [The preliminary study on in vitro differentiation of human umbilical cord blood cells into neural cells]. 2003 Zhonghua Xue Ye Xue Za Zhi pmid:14575594
Wang BL et al. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells]. 2008 Zhonghua Yi Xue Za Zhi pmid:19062743
Xiang GD et al. [Changes in plasma concentrations of osteoprotegerin before and after levothyroxine replacement therapy in hypothyroid patients]. 2007 Zhonghua Yi Xue Za Zhi pmid:17988532
Xiao XH et al. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. 2004 Zhonghua Yi Xue Za Zhi pmid:15730627
Zhong N et al. [Relationship between polymorphism of parathyroid hormone and bone mineral density and relevant biochemical indicators in women]. 2006 Zhonghua Yi Xue Za Zhi pmid:16677544

Table of Content